Netherlands Insider Trading Transactions
Latest insider transactions reported to the AFM
Showing 4851 – 4900 of 7,506 transactions
| Issuer | Insider | Position | Transaction | Price | Volume | Transaction Date | Trading Venue | Details |
|---|---|---|---|---|---|---|---|---|
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Ferrovial N.V. | Aguirre M.J. | Chief Executive Officer of Ferovial Energy | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Banijay Group N.V. | Vivendi SE | Non-Executive Director of Banijay Group N.V. | Vervreemding | EUR 8.73 | EUR 1,082.52 | 30 Jun 2025 | TP ICAP EU - MTF | |
| Banijay Group N.V. | Vivendi SE | Non-Executive Director of Banijay Group N.V. | Vervreemding | EUR 8.70 | EUR 1,035.30 | 30 Jun 2025 | POSIT DARK | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| NN Group N.V. | Nihot D. | Management Board Member NN Group N.V. | Vervreemding | EUR 56.28 | EUR 292,993.68 | 30 Jun 2025 | OTC | |
| Banijay Group N.V. | Vivendi SE | Non-Executive Director of Banijay Group N.V. | Vervreemding | EUR 8.55 | EUR 172,342.35 | 30 Jun 2025 | EURONEXT - EURONEXT AMSTERDAM | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Universal Music Group N.V. | Ellis M. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| Ferrovial N.V. | Aguirre M.J. | Chief Executive Officer of Ferovial Energy | Verwerving | EUR 0.00 | EUR 0.00 | 30 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Vervreemding | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Truyen L. | Chief Medical Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Moorthy H. | General Counsel | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Gubitz K. | Chief Financial Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Massey K. | Chief Operating Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Ulrichts P. | Chief Scientific Officer | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Wilk A. | Global Head of Quality | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| argenx SE | Lemmen A. | Vice President of Corporate Development & Strategy | Verwerving | EUR 0.00 | EUR 0.00 | 28 Jun 2025 | OTC | |
| Accsys Technologies Plc. | Os, van J.A. | Chief Executive Officer | Verwerving | EUR 0.00 | EUR 0.00 | 27 Jun 2025 | OTC | |
| Accsys Technologies Plc. | Os, van J.A. | Chief Executive Officer | Verwerving | EUR 0.00 | EUR 0.00 | 27 Jun 2025 | OTC | |
| Accsys Technologies Plc. | Os, van J.A. | Chief Executive Officer | Verwerving | EUR 0.00 | EUR 0.00 | 27 Jun 2025 | OTC | |
| Accsys Technologies Plc. | van Os J.A. | Chief Executive Officer | Verwerving | EUR 0.00 | EUR 0.00 | 27 Jun 2025 | OTC |